MedPath

华夏药业集团有限公司

Ownership
-
Established
2002-01-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

NMPA:21

Drug Approvals

Nateglinide Tablets

Product Name
参可欣
Approval Number
国药准字H20060504
Approval Date
Aug 10, 2015
NMPA

Ibudilast

Product Name
异丁司特
Approval Number
国药准字H20030915
Approval Date
Jul 24, 2015
NMPA

Sertraline Hydrochloride

Product Name
盐酸舍曲林
Approval Number
国药准字H20059429
Approval Date
Jun 23, 2015
NMPA

Benidipine Hydrochloride

Product Name
盐酸贝尼地平
Approval Number
国药准字H20030078
Approval Date
Apr 10, 2015
NMPA

Sertraline Hydrochloride Tablets

Product Name
盐酸舍曲林片
Approval Number
国药准字H20051285
Approval Date
Apr 10, 2015
NMPA

止咳祛痰颗粒

Approval Number
国药准字Z20033283
Approval Date
Apr 10, 2015
NMPA

Ibudilast Sustained Release Capsules

Product Name
异丁司特缓释胶囊
Approval Number
国药准字H20030916
Approval Date
Apr 10, 2015
NMPA

脑得生片

Approval Number
国药准字Z20043181
Approval Date
Apr 10, 2015
NMPA

Glipizide Dispersible Tablets

Product Name
格列吡嗪分散片
Approval Number
国药准字H20031028
Approval Date
Apr 10, 2015
NMPA

Nimodiping Injection

Product Name
尼莫地平注射液
Approval Number
国药准字H20053554
Approval Date
Sep 30, 2010
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.